(R)-benzyl (1-amino-4-methyl-1-oxopentan-3-yl)carbamate | 173336-92-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-benzyl (1-amino-4-methyl-1-oxopentan-3-yl)carbamate
• 英文别名: benzyl N-[(3R)-1-amino-4-methyl-1-oxopentan-3-yl]carbamate
• CAS: 173336-92-0
• 化学式: C₁₄H₂₀N₂O₃
• 分子量: 264.324
• InChiKey: WGGJCFNNECPOFX-GFCCVEGCSA-N

物化性质

• 沸点：
  481.3±38.0 °C(Predicted)
• 密度：
  1.124±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  19
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  81.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (R)-benzyl (1-amino-4-methyl-1-oxopentan-3-yl)carbamate 在 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 反应 1.5h， 生成 (R)-3-methyl-1-(4H-1,2,4-triazol-3-yl)butan-2-amine
  参考文献：
  名称：

  [EN] FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME
  [FR] COMPOSÉS DE FUMAGILLOL, ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION

  摘要：

  本文披露了富马醇类化合物及其在治疗医学疾病（如肥胖症）中的用途方法。提供了富马醇类化合物的药物组合物和制备方法。这些化合物被认为对蛋氨酸氨肽酶2具有活性。

  公开号：

  WO2018031877A1
• 作为产物：
  描述：

  CBZ-L-Β-亮氨酸 在 三乙胺 、 氯甲酸乙酯 、 ammonium hydroxide 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以3.7 g的产率得到(R)-benzyl (1-amino-4-methyl-1-oxopentan-3-yl)carbamate
  参考文献：
  名称：

  [EN] FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME
  [FR] COMPOSÉS DE FUMAGILLOL, ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION

  摘要：

  本文披露了富马醇类化合物及其在治疗医学疾病（如肥胖症）中的用途方法。提供了富马醇类化合物的药物组合物和制备方法。这些化合物被认为对蛋氨酸氨肽酶2具有活性。

  公开号：

  WO2018031877A1

文献信息

• Methods of treating alzheimer's disease using aryl alkanoic acid amides
  申请人：John Varghese

  公开号：US20060154926A1

  公开（公告）日：2006-07-13

  Disclosed are methods for treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula (1) wherein the variables R 1 -R 8 and X are defined herein.

  本发明涉及使用式（1）中所述的化合物治疗阿尔茨海默病和其他疾病，抑制β-分泌酶酶活性和/或抑制Aβ肽在哺乳动物体内的沉积的方法，其中变量R1-R8和X在此定义。
• Synthesis of novel N-protected β3-amino nitriles: study of their hydrolysis involving a nitrilase-catalyzed step
  作者：Maité Sylla-Iyarreta Veitía、Pierre Louis Brun、Pierre Jorda、Annie Falguières、Clotilde Ferroud

  DOI：10.1016/j.tetasy.2009.07.045

  日期：2009.9

  Several commercially available nitrilases were investigated with regard to their potential to hydrolyze N-protected beta(3)-amino nitriles into their corresponding N-protected beta(3)-amino acids.The biotransformations were obtained in different proportions depending oil the nitrilase involved The best hydrolysis results were achieved for the N-Cbz-beta(3)-amino nitrile from i-alanine using the NIT-107, in a phosphate buffer at 0 05 M However, no biotransformation into the corresponding acids was observed for the N-sulfonylamide beta(3)-amino nitriles. Two simple and efficient procedures to prepare the beta(3)-amino nitriles from their analogous alpha-amino acids are described Thirty four new substances were synthesized and characterized over the course of this work. (C) 2009 Elsevier Ltd All rights reserved
• Delta-Amino-gamma-hydroxy-omega-aryl-alkansäureamide mit Enzym-, insbesondere Renin-hemmenden Eigenschaften
  申请人：Novartis AG

  公开号：EP0678503B1

  公开（公告）日：1999-09-01
• Novel inhibitors of Hepatitis C virus NS3 protease
  申请人：Bogen L. Stephane

  公开号：US20070142301A1

  公开（公告）日：2007-06-21

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
• FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME
  申请人：Zafgen, Inc.

  公开号：US20190169181A1

  公开（公告）日：2019-06-06

  Disclosed herein, in part, are fumagillol compounds and methods of use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making fumagillol compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.